Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 2 , Pages 86-97 , June 2010

Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT

References 

  1. Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol. 2001;74:656–669
  2. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res. 2000;33:869–880
  3. Henderson BW, Dougherty TJ. How does photodynamic therapy work?. Photochem Photobiol. 1992;55:145–157
  4. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. BJC. 1996;74:22–29
  5. Calzavara-Pinton PG, Venturini M, Sala R. Photodynamic therapy: update 2006. Part 2. Clinical results. J European Acad Derm Vene. 2007;21:439–451
  6. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation. BJD. 1994;130:743–751
  7. Malik Z, Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. BJC. 1987;56:589–595
  8. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. JPPB. 2001;62:140–145
  9. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65:235–251
  10. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79:2282–2308
  11. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. BJD. 2002;146:552–567
  12. Moan J, Iani V, Ma LW. In:  Benjamin E,  Giulio J,  Moan J editor. Choice of the proper wavelength for photochemotherapy. SPIE; 1996;p. 544–549
  13. Scott MA, Hopper C, Sahota A, et al. Fluorescence photodiagnosis and photobleaching studies of cancerous lesions using ratio imaging and spectroscopic techniques. Lasers Med Sci. 2000;15:63–72
  14. Wennberg AM, Gudmundson F, Stenquist B, et al. In vivo detection of basal cell carcinoma using imaging spectroscopy. Acta Derm Venereol. 1999;79:54–61
  15. Ackermann G, Abels C, Karrer S, Baumler W, Landthaler M, Szeimies RM. Fluorescence-assisted biopsy of basal cell carcinomas. Hautarzt. 2000;51:920–924
  16. Siewecke C, Szeimies RM. PDT and fluorescence diagnosis in dermatology. Hosp Pharm Europe. 2004;(May/June):49–52
  17. Bogaards A, Sterenborg HJ, Trachtenberg J, Wilson BC, Lilge L. In vivo quantification of fluorescent molecular markers in real-time by ratio imaging for diagnostic screening and image-guided surgery. Lasers Surg Med. 2007;39:605–613
  18. Smits T, Kleinpenning MM, Blokx WA, van de Kerkhof PC, van Erp PE, Gerritsen MJ. Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Derm. 2007;57:824–831
  19. Bogaards A, Aalders MC, Zeyl CC, et al. Localization and staging of cervical intraepithelial neoplasia using double ratio fluorescence imaging. J Biomed Opt. 2002;7:215–220
  20. Hua Z, Gibson SL, Foster TH, Hilf R. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitiser for photodynamic therapy in vivo. Cancer Res. 1995;55:1723–1731
  21. Loh CS, Vernon D, MacRobert AJ, Bedwell J, Bown SG, Brown SB. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. JPPB. 1993;20:47–54
  22. Andersson-Engels S, Klinteberg C, Svanberg K, Svanberg S. In vivo fluorescence imaging for tissue diagnostics. Phys Med Biol. 1997;42:815–824
  23. Boere IA, Robinson DJ, de Bruijn HS, et al. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol. 2003;78:271–277
  24. Ericson MB, Sandberg C, Stenquist B, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. BJD. 2004;151:1204–1212
  25. Loschenov VB, Konov VI, Prokhorov AM. Photodynamic therapy and fluorescence diagnostics. Laser Phys. 2000;10:1188–1207
  26. Berg K, Selbo PK, Weyergang A, et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J Microsc. 2005;218:133–147
  27. Smits T, Kleinpenning MM, van Erp PE, van de Kerkhof PC, Gerritsen MJ. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. BJD. 2006;155:429–436
  28. Ascencio M, Collinet P, Farine MO, Mordon S. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg Med. 2008;40:332–341
  29. Bogaards A, Sterenborg HJ, Wilson BC. In vivo quantification of fluorescent molecular markers in real-time: a review to evaluate the performance of five existing methods. Photodiagn Photodyn Ther. 2007;4:170–178
  30. Kleinpenning MM, Smits T, Ewalds E, van Erp PE, van de Kerkhof PC, Gerritsen MJ. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study. BJD. 2006;155:539–545
  31. Martin A, Tope WD, Grevelink JM, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Derm Res. 1995;287:665–674
  32. Smits T, Robles CA, van Erp PE, van de Kerkhof PC, Gerritsen MJ. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol. 2005;125:833–839
  33. Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981;77:13–19
  34. Bashkatov AN, Genina EA, Kochubey VI, Tuchin VV. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000nm. J Phys D: Appl Phys. 2005;38:2543–2555
  35. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol. 1998;67:140–149
  36. Bech O, Berg K, Moan J. The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid. Cancer Lett. 1997;113:25–29
  37. Bedwell J, MacRobert AJ, Phillips D, Bown SG. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. BJC. 1992;65:818–824
  38. Berg K, Anholt H, Bech O, Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. BJC. 1996;74:688–697

PII: S1572-1000(10)00033-5

doi: 10.1016/j.pdpdt.2010.03.002

Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 2 , Pages 86-97 , June 2010

Article Tools

* Image Usage & Resolution